 |
Plunkett's Biotechnology, Drugs & Genetics Industry
Market research, business trends & statistics analysis, & business development support |  | | Get market research, industry analysis, corporate profiles, and decision makers in one resource! With Plunkett's Biotechnology, Drugs & Genetics Industry data you get the competitive intelligence you need to fully understand business trends, technologies, markets, finances and the leading companies. And, you can export mailing lists of companies and executives. |
|
| Online Access | 
Online Access:
Fast and Affordable
24/7 web-based access to our Industry Research & Business Development Center. From $149.99
> More Info Buy Now |
|
| | Almanac & CD-ROM | 
Plunkett's Biotechnology & Genetics Industry Almanac
2009 Edition, 572 Pages
ISBN: 1-59392-124-1
Price: $299.99
Published Date: August 2008
(Next Edition: August 2009
> More Info Buy Now |
|
| |
Biotechnology, Drugs & Genetics business trends analyzed | | The following trends are provided in our research products: |
| - The State of the Biotechnology Industry Today > (View Sample Data)
- A Short History of Biotechnology
- Ethanol Production Soared, But a Market Glut May Slow Expansion
- New Money Pours into Biotech Firms/Mergers and Acquisitions Surge Ahead
- Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms
- From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development
- Gene Therapies and Patients’ Genetic Profiles Promise a Personalized Approach to Medicine
- New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment—Many More Will Follow
- Few New Blockbusters: Major Drug Patents Expire While Generic Sales Soar
- Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age
- Biogenerics (Follow-on Biologics) are in Limbo in the U.S.
- Breakthrough Drug Delivery Systems Evolve
- Stem Cells—Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race
- Stem Cell Funding Trickles in the U.S. at the Federal Level While a Few States Create Funding of Their Own
- Stem Cells—Therapeutic Cloning Techniques Advance
- Stem Cells—A New Era of Regenerative Medicine Looms
- Nanotechnology Converges with Biotech
- Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise
- Focus on Vaccines
- Ethical Issues Abound
- Technology Discussion—Genomics
- Technology Discussion—Proteomics
- Technology Discussion—Microarrays
- Technology Discussion—DNA Chips
- Technology Discussion—SNPs (“Snips”)
- Technology Discussion—Combinatorial Chemistry
- Technology Discussion—Synthetic Biology
- Technology Discussion—Recombinant DNA
- Technology Discussion—Polymerase Chain Reaction (PCR)
| |
Biotechnology, Drugs & Genetics business statistics analyzed | | The following statistical tables are provided in our research products: |
| - Biotech Industry Overview > (View Sample Data)
- Global Biotechnology at a Glance: 2006
- Growth in Global Biotechnology: 2005-2006
- Biotechnology Financing, U.S., Europe & Canada: 2005-2006
- U.S. Biotechnology at a Glance: 2005-2006
- Quarterly Breakdown of Biotechnology Financings, U.S. & Canada: 2006
- Ernst & Young Survival Index, U.S. & Canadian Biotechnology Companies: 2005-2006
- Global Area of Biotech Crops by Country: 2006
- Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2005
- Plant-Derived Pharmaceuticals for the Treatment of Human Diseases that are in the Pipeline for Commercialization: 2007
- The U.S. Drug Discovery & Approval Process
- U.S. FDA Approval Times for New Drugs: 1993-2006
- U.S. FDA Approval Times for New Molecular Entities (NMEs): 1993-2006
- Domestic Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1970-2006
- Domestic Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2005
- R&D By Global Geographic Area, PhRMA Member Companies: 2005
- R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2006
- U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2006
- Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1970-2006
- Domestic & Foreign Pharmaceutical Sales by End Use & Customer, PhRMA Member Companies: 2005
- Generics' Share of the U.S. Drug Market by Volume: 1984-2007
- National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2001-2016
- Prescription Drug Expenditures, U.S.: 1965-2016
- U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2001-2016
- 20 Largest Global Pharmaceutical Companies: 2005-2006
- Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2006-2008
- Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2005-2007
- Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2006
- Domestic Biopharmaceutical R&D Scientific, Professional, and Technical Personnel by Function, PhRMA Member Companies: 2005
| |
Overview of Plunkett's Biotechnology, Drugs & Genetics Industry coverage | |
The biotechnology field is finally beginning to blossom. Venture capital and private placement funding are pouring into biotech firms, and scores of promising new drugs are in Phase I and Phase II clinical trials. Laboratories at leading universities are partnering with leading pharmaceuticals companies to push research and development along at faster levels. Meanwhile, nations such as China, India, Taiwan, South Korea and Singapore are fostering innovation with massive investments in new R&D centers of their own—many of which are focused on stem cell technology. The promise of personalized medicine is starting to come into fruition, with many types of personal genetic diagnostic services being offered in the U.S. Also, genetically-modified (GM) foods are benefiting from the development of agricultural biotechnology at leading suppliers. Biochemicals are starting to revolutionize the polymers and specialty chemicals sectors. And biodiesel and other biomass fuels are taking hold.
This carefully-researched book (which includes a database of leading companies on CD-ROM) is a complete biotechnology and genetics market research and business intelligence tool— everything you need to know about the business of biotechnology, proteomics, stem cells, GMOs, agricultural biotechnology, biopharmaceuticals and more.
Our coverage includes biotechnology business trends analysis and genetics industry statistics. We also include a biotechnology business glossary and a listing of biotechnology industry contacts, such as industry associations and government agencies. Next, we profile hundreds of leading biotechnology companies, such as drug manufacturers, bioinformatics and genetics database providers, clinical trials companies and contract manufacturers—a broad range of biotech sector companies. Our company profiles include complete business descriptions and up to 27 executives by name and title. Both online and printed versions of Plunkett’s Biotechnology & Genetics Industry enable you to search, filter and view selected companies and leagues, and then to export selected company contact data, including executive names, either online or via the CD-ROM that is included with the book versions.
In Plunkett’s Biotechnology & Genetics Industry Almanac, you’ll find extensive biotech business coverage, including:
- Market research, competitive intelligence and business analysis for all biotechnology business sectors.
- Analysis of trends in biotechnology and biopharmaceuticals research, development, clinical trials and regulatory affairs, including developments at the FDA.
- Trends in biotechnology funding, M&A, joint ventures, California state funding and venture capital.
- Trends in stem cells, regenerative medicine and cloning research and regulation
- Growing investments in biotechnology and stem cell research in such nations as India, China and Singapore.
- Biotechnology business statistics, including information on patents and patenting.
- Cancer therapies.
- Biosecurity, bioterrorism deterrents and homeland security.
- Personalized medicine, gene therapy and kinase inhibitors.
- Systems biology, synthetic biology.
- The convergence of nanotechnology and biotechnology.
- Profiles of 450 leading biotechnology firms.
- Assays, diagnostics, lab on a chip.
- Profiles of leading drug manufacturers in the U.S., U.K., Europe, Asia and Canada.
- Profiles of leading genetic database firms, genomics consulting companies and proteomics data providers.
- Biochemicals, biofuels, biomass and biodiesel.
You'll find a complete overview, industry analysis and market research report in one superb, value-priced package. This book also includes statistical tables, a biotechnology industry glossary, industry contacts and thorough indexes. The corporate profile section of the book includes our proprietary, in-depth profiles of the 450 leading companies in all facets of the biotechnology and genetics industry. This book is available in printed, eBook and online versions. Purchasers may also receive a free copy of the company profiles database on CD-ROM.
Reviews: "…A book/CD-ROM reference guide to the business side of biotech, genetics, proteonics and related services. Offers profiles of 450 leading biotech companies, plus overviews of trends in biotech, technology, finances and careers which will help readers understand the uses and implications of such technologies as tissue engineering, recombinant DNA and genetically engineered agricultural products…. The CD-ROM contains corporate profiles (of leading biotech companies) and executive names by title, and can be used for mail merge and financial charts."
SciTech Book News
"For business researchers and job seekers, this almanac provides an overview of leading biotechnology firms and descriptions of emerging technology… The company and industry overviews make this a worthwhile addition to business and career reference collections."
CHOICE magazine
“The simple and straight-forward structure and presentation of information is a real asset, making for very intuitive application. A companion CD enables the creation of mailing lists, permits the creation of customized spreadsheets and databases and the ability to sort, filter and view the corporate profiles...
Plunkett’s Biotech and Genetics Industry Almanac is an essential addition to any biotechnology executive’s bookshelf.”
Yali Friedman, Biotech/Biomedical Editor, About.com
“One more fine example of the fine publications offered by Plunkett Research. This reference books is particularly timely given the considerable interest in biotech and genetics from scientific, investment and entrepreneurial audiences…Will be an excellent source for nearly any kind of library.”
American Reference Books Annual
| |
Key Biotechnology, Drugs & Genetics Topics | Biopharmaceuticals
Genetically Modified (GM) Foods and Bioagriculture (AGRIBIO)
Diagnostics
FDA
Personalized Medicine
Systems Biology
Regulation
Research and Development (R&D)
Stem Cells | Cloning
Drug Discovery
Clinical Trials
Bioanalysis
Partnerships
Funding Distribution
Profiles of Leading Biotechnology Companies
Executive Mailing Lists | |
|
|
|
|